Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRolls-Royce Regulatory News (RR.)

Share Price Information for Rolls-Royce (RR.)

Share Price is delayed by 15 minutes
Get Live Data
1,391.20    -20.60 (-1.46%)
Bid:
1,402.80
Ask:
1,403.40
Spread: 0.60 (0.043%)
Market Cap: £115.30b
RR. Live PriceLast checked at - London Stock Exchange

Intraday Rolls-Royce Share Chart

Director/PDMR Shareholding

1 Nov 2019 16:00

RNS Number : 9890R
Rolls-Royce Holdings plc
01 November 2019
Β 

Β 

ROLLS-ROYCE HOLDINGS plc

Β 

Rolls-Royce Holdings plc (Company) announces that on 31 October 2019, ordinary shares in the company were transferred to Stephen Daintith, a person discharging managerial responsibility (PDMR) by Computershare Trustees (Jersey) Limited (the trustee of the Rolls-Royce Employee Share Trust) in relation to the automatic vesting of an award made under the Rolls-Royce Performance Share Plan (PSP) on 5th May 2017. In addition, shares were sold by the Trustee, on behalf of Stephen Daintith, to discharge his tax obligations arising from the release of the shares. Details of the number of shares sold and net shares released to Stephen Daintith, at a vesting price of Β£7.1098 per share, are set out below.

Β 

Number of Shares vested 103,644

Number of Shares sold to discharge tax liability 48,713

Number of Shares released to Stephen Daintith 54,931

Β 

The formal notification can be found on the following page.

Β 

Β 

Β 

ANNEX

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Stephen Daintith

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β 

Chief Financial Officer

b)

Β 

Initial notification /Amendment

Β 

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Β 

Rolls-Royce Holdings plc

b)

Β 

LEI

Β 

Β 

213800EC7997ZBLZJH69

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Β 

Β 

Ordinary Shares

Β 

GB00B63H8491

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Vesting of award made under the Rolls-Royce Performance Share Plan

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£7.1098

Β 

103,644

Β 

Β 

d)

Β 

Aggregated information

Β 

Β 

- Aggregated volume

Β 

Β 

- Price

Β 

Β 

Β 

Β 

Not applicable - vesting of award

Β 

Β 

Β 

Β 

Β 

e)

Β 

Date of the transaction

Β 

Β 

31 October 2019

f)

Β 

Place of the transaction

Β 

Β 

London Stock Exchange, Main Market (XLON)

Β 

Β 

Dated 1 November 2019

Β 

For further information please contact:

Β 

Carolyn Sharpe

Senior Corporate Governance Manager

Rolls-Royce Holdings plc

Tel. no: 01332 245096

Email: Carolyn.Sharpe@Rolls-Royce.com

Β 

Media:

Richard Wray

Director of External Communications

Rolls-Royce plc

Tel: +44 (0)20 7227 9163

richard.wray@rolls-royce.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHBGBDBSUGBGCB
Date   Source Headline
2nd Aug 20237:00 amRNSDirectorate Change
31st Jul 20239:30 amRNSDirector/PDMR Shareholding
26th Jul 20237:00 amRNSTrading Update
20th Jul 20239:00 amRNSDirectorate Change
10th Jul 20233:30 pmRNSDirector/PDMR Shareholding
3rd Jul 20239:32 amRNSTotal Voting Rights
28th Jun 20233:30 pmRNSDirector/PDMR Shareholding
27th Jun 202312:00 pmRNSAdmission of Shares
8th Jun 20232:00 pmRNSDirector/PDMR Shareholding
30th May 202312:00 pmRNSDirector/PDMR Shareholding
19th May 202312:00 pmRNSDirector/PDMR Shareholding
11th May 20232:07 pmRNSResult of AGM
11th May 20239:14 amRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSAGM Statement and Trading Update
10th May 20234:00 pmRNSDirectorate change & withdrawal of AGM resolution
28th Apr 20233:44 pmRNSDirector/PDMR Shareholding
14th Apr 20239:30 amRNSDirector/PDMR Shareholding
11th Apr 20231:00 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSDirectorate Change
29th Mar 20239:34 amRNSDirector/PDMR Shareholding
21st Mar 20233:03 pmRNSDirector/PDMR Shareholding
17th Mar 20233:00 pmRNSDirector/PDMR Shareholding
10th Mar 20232:35 pmRNSDirector/PDMR Shareholding
8th Mar 20233:39 pmRNSDirector/PDMR Shareholding
2nd Mar 20239:00 amRNSAnnual Report 2022 and Annual General Meeting 2023
1st Mar 20235:05 pmRNSHolding(s) in Company
28th Feb 20234:17 pmRNSDirector/PDMR Shareholding
24th Feb 202312:00 pmRNSDirector/PDMR Shareholding
23rd Feb 20237:00 amRNS2022 Full Year Results
10th Feb 20239:09 amRNSDirector Declaration
9th Feb 20239:30 amRNSDirector/PDMR Shareholding
9th Feb 20237:00 amRNSDirectorate Change
31st Jan 20239:30 amRNSDirector/PDMR Shareholding
11th Jan 20233:50 pmRNSDirector/PDMR Shareholding
22nd Dec 202211:05 amRNSDirector/PDMR Shareholding
21st Dec 20229:37 amRNSDirectorate Change
8th Dec 20222:37 pmRNSDirector/PDMR Shareholding
5th Dec 20224:04 pmRNSDirector/PDMR Shareholding
29th Nov 20229:30 amRNSDirector/PDMR Shareholding
18th Nov 202210:07 amRNSHolding(s) in Company
14th Nov 202210:00 amRNSHolding(s) in Company
10th Nov 20229:15 amRNSHolding(s) in Company
9th Nov 20222:40 pmRNSDirector/PDMR Shareholding
3rd Nov 20227:00 amRNSTrading Statement
31st Oct 20229:30 amRNSDirector/PDMR Shareholding
18th Oct 20222:45 pmRNSDirector Declaration
13th Oct 20223:15 pmRNSHolding(s) in Company
10th Oct 20225:11 pmRNSDirector/PDMR Shareholding
10th Oct 20229:30 amRNSHolding(s) in Company
5th Oct 20225:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.